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Toxocara  canis has  extraordinary  abilities  to survive  for many  years  in  the  tissues  of diverse
vertebrate species,  as  well  as  to  develop  to maturity  in  the  intestinal  tract  of its  deﬁni-
tive  canid  host.  Human  disease  is  caused  by  larval  stages  invading  musculature,  brain  and
the eye,  and immune  mechanisms  appear  to be  ineffective  at eliminating  the  infection.
Survival  of  T.  canis  larvae  can  be  attributed  to  two  molecular  strategies  evolved  by the  par-
asite. Firstly,  it  releases  quantities  of  ‘excretory–secretory’  products  which  include  lectins,
mucins  and  enzymes  that interact  with  and  modulate  host  immunity.  For  example,  one
lectin  (CTL-1)  is  very  similar  to mammalian  lectins,  required  for  tissue  inﬂammation,  sug-
gesting  that T. canis  may  interfere  with  leucocyte  extravasation  into  infected  sites.  The
second  strategy  is  the  elaboration  of  a specialised  mucin-rich  surface  coat;  this  is loosely
attached  to the  parasite  epicuticle  in  a fashion  that  permits  rapid  escape  when  host  antibod-
ies and  cells  adhere,  resulting  in an inﬂammatory  reaction  around  a newly  vacated  focus.
The mucins  have  been  characterised  as bearing  multiple  glycan  side-chains,  consisting  of
a blood-group-like  trisaccharide  with  one  or two  O-methylation  modiﬁcations.  Both  the
lectins and  these  trisaccharides  are  targeted  by  host  antibodies,  with  anti-lectin  antibodies
showing  particular  diagnostic  promise.  Antibodies  to the  mono-methylated  trisaccharide
appear  to  be  T. canis-speciﬁc,  as  this  epitope  is not  found  in the  closely  related  Toxocara  cati,
but all  other  antigenic  determinants  are  very  similar  between  the  two  species.  This distinc-
tion may  be  important  in  designing  new  and  more  accurate  diagnostic  tests.  Further  tools
to control  toxocariasis  could  also arise  from  understanding  the  molecular  cues  and  steps
involved in  larval  development.  In vitro-cultivated  larvae  express  high  levels  of four  mRNAs
that are  translationally  silenced,  as  the  proteins  they  encode  are  not  detectable  in  cultured
larvae. However,  these  appear  to be produced  once  the  parasite  has  entered  the mam-
malian  host,  as  they  are  recognised  by  speciﬁc  antibodies  in  infected  patients.  Elucidating
the  function  of  these  genes,  or  analysing  if micro-RNA  translational  silencing  suppresses
production  of  the proteins,  may  point  towards  new  drug  targets  for tissue-phase  parasites
in humans.
© 2013 Elsevier B.V. All rights reserved.
1. Introduction
Toxocara canis is the most prevalent intestinal round-
worm of dogs, foxes and other canid species, with zoonotic
potential for human beings. In many temperate countries,
toxocariasis is the most common helminth infection and
∗ Tel.: +44 131 650 5511; fax: +44 131 650 5450.
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causes a signiﬁcant morbidity (Despommier, 2003; Hotez
and Wilkins, 2009; Rubinsky-Elefant et al., 2010; Smith
et al., 2009).
The nematode has many salient biological features,
which contribute to its continuing presence in animal
and human populations. Firstly, it is able to invade an
extraordinarily wide range of hosts, from invertebrates and
poultry (Galvin, 1964) through to mice and man  (Strube
et al., 2013); for all but the deﬁnitive (canid) species,
these represent intermediate hosts which can, through
0304-4017/$ – see front matter ©  2013 Elsevier B.V. All rights reserved.
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predation, allow the parasite to reach its ﬁnal deﬁnitive
host species. Secondly, the larval stage is able to enter a
long-term developmental arrest, which allows it to sus-
pend life cycle progression whilst in a paratenic host, and to
resume maturation to the adult stage only once reaching a
canid species. Thirdly, even in female canids, developmen-
tal arrest occurs so that larvae can dwell in tissues until
pregnancy occurs, and then migrate transplacentally or via
colostrum to infect the foetal or newborn pup (Schnieder
et al., 2011).
T. canis is highly prevalent in all canid populations
that are not treated regularly with anthelmintics, and
its infectivity to wild species renders elimination almost
impossible. Furthermore, the arrested state has remarkable
longevity: in experimentally infected monkeys for exam-
ple, larvae remained viable in the tissues for 9 years and
were able to infect mice on transfer (Beaver, 1962).
Within the paratenic host, T. canis larvae can migrate
widely including the liver, musculature and the central ner-
vous system, causing the well-characterised syndrome of
visceral larva migrans (VLM) (Beaver et al., 1952; Carvalho
and Rocha, 2011; Schantz, 1989). The propensity to invade
the brain and the eye has given rise to particular con-
cern in the human population, with ocular toxocariasis
(OT) a recognised syndrome (Good et al., 2004), and neu-
rotoxocariasis (NT) inferred from cognitive deﬁcits, higher
prevalence among epilepsy cases (Quattrocchi et al., 2012),
and ﬁnding larvae in post-mortem brain samples (Hill
et al., 1985). Current options for treatment of humans
infected with tissue-dwelling larvae are of uncertain efﬁ-
cacy because of the covert nature of the infection and
the incomplete resolution of symptoms (Othman, 2012;
Wis´niewska-Ligier et al., 2012).
2. Immune recognition
Pathogens are recognised initially by the innate immune
system reacting to intrinsically foreign molecular signa-
tures associated with xenogeneic species, such as bacterial
lipopolysaccharide, unmethylated DNA and fungal carbo-
hydrates. Such signals are essential for innate immune
sentinel cells, such as dendritic cells, to react to the
presence of infectious organisms and to initiate pathogen-
speciﬁc responses from the adaptive immune system.
Currently, few such “pathogen-associated molecular pat-
terns” (PAMPs) have been deﬁned for any helminth
parasite, but their existence in T. canis can be surmised
by the strong adaptive immune response that occurs in
this infection. The major feature of this adaptive immune
response is production of T. canis-speciﬁc antibodies, asso-
ciated with CD4+ T-helper type 2 cell (Th2) activity (Del
Prete et al., 1991).
Such a Th2 response is characterised by release of
a speciﬁc subset of mediators, in particular the type 2
cytokines IL-4, -5, -10 and -13, during infection. Subse-
quently, IL-4 promotes B cell differentiation and antibody
class-switching, while IL-5 drives the differentiation of
eosinophils, a marked feature of human Toxocara spp. infec-
tion (Beaver et al., 1952). T cell responses to T. canis in
human beings are clearly of the Th2 type, and are stim-
ulated by the “excretory–secretory” (ES) antigens of the
parasite (Del Prete et al., 1991). However, no individual T
cell speciﬁc antigen or epitope has yet been deﬁned from
T. canis.
Recently, the distinction between innate and adap-
tive arms of immunity has become much more blurred
with identiﬁcation of innate lymphoid cells, which can
rapidly produce Type-2 cytokines (Neill et al., 2010) with-
out requiring activation by dendritic cells (Smith et al.,
2012). Indeed, it has been known for some time that some
innate populations of cells can participate in the “Th2
response” to T. canis, for example non-B-non-T cells pro-
duce IL-5, even in T cell-deﬁcient nude mice infected with
the parasite (Takamoto et al., 1995). Moreover, eosinophilia
in infected mice shows a biphasic response with early (day
10) and late (day 21) peaks; while the later peak is absent
in CD4+ T cell-deﬁcient mice, the earlier one is intact, indi-
cating that it is generated by the innate rather than the
adaptive Type-2 response (Takamoto et al., 1998).
Generation of speciﬁc antibodies provides the most
deﬁnitive evidence for infection and is the basis for all
diagnostic tests for toxocariasis; with ELISA and West-
ern blot reactivity to T. canis ES (TES) antigens generally
employed. However, the diagnostic ﬁeld is still evolving
with respect to the optimal target antigens that should
be used, and more critically to the interpretation of anti-
body reactivity to an infection which is frequently covert
and in which symptoms do not necessarily correlate with
infection intensity or antibody titre (Smith et al., 2009).
There are now extensive data on the seroprevalence
of anti-TES antibodies in human populations around the
world, using the established ELISA. In older studies,
seropositivity in Europe ranged from 3 to 7% in adults and
7 to 23% in children (Gillespie et al., 1993), while in the USA
13.9% of those over 6 years of age were antibody-positive
(Won  et al., 2008). Remarkably, seroprevalences exceeded
50% in tropical settings such as the Caribbean (Bundy et al.,
1987; Magnaval et al., 1994). More recent studies simi-
larly report seroprevalences of 14.5% in Polish teenagers
(Jarosz et al., 2010), 13% in Turkish children (Dog˘an et al.,
2007) and 9% in Iranian under-10s (Fallah et al., 2007), ris-
ing to 27% in Brazilian Amazonia (Rubinsky-Elefant et al.,
2008) and 45–82% in different rural districts of Sulawesi,
Indonesia (Hayashi et al., 2005). Hence widespread toxo-
cariasis remains of great concern in most parts of the world.
The question of which serum antibody isotypes are
most relevant still remains to be explored. Most human
infections generate antibodies of the IgG1 subclass, with
signiﬁcant levels of both IgM and IgE (Smith, 1993). The
IgG4 isotype, which can be predominant in other, more
intense, tissue helminth infections such as ﬁlariasis and
schistosomiasis (Maizels et al., 1995) is less prominent,
although reportedly more evident in active cases of vis-
ceral larva migrans (Obwaller et al., 1998). An unresolved
issue is whether the expression of IgE correlates with active
infection and/or invasion of certain tissue sites in the host,
or possibly mediates only bystander allergic-type reactions
such as infection-related rashes (Magnaval et al., 2006).
Related to this question is whether particular isotypes are
functionally important in tissue immunity, for example
by trapping larvae or activating Fc-dependent protection
mechanisms.
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Recent analyses of differential expression proﬁles of
anti-Toxocara spp. antibody isotypes, studying children
receiving thiabendazole therapy, found that speciﬁc IgE
and eosinophilia declined within the ﬁrst year, with IgA
and IgG4 falling at later times (Elefant et al., 2006). Such
information may  prove useful in addressing the need for
new immunological markers that could be used to chart
the success of therapy in drug-treated patients.
3. Immunity in the deﬁnitive host
Although almost all immunological studies on T. canis
have centred a round the tissue-migrating larvae, the
immune response of the ﬁnal canid host to intestinal adult
worms is also of central importance. A long-term aim
of research in this area is to develop an effective vac-
cine against canine toxocariasis, which ideally would build
immunity to both tissue- and intestinal stages of the para-
site.
Intestinal immunity to ascarid worms is poorly under-
stood; taking a comparative approach, based on animal
models of taxonomically distant nematodes (e.g. Nip-
postrongylus brasiliensis,  Trichuris muris), it would be
predicted that Th2-dependent mechanisms act to expel
the parasites, but the cell types and molecular mediators
participating in expulsion are as yet unknown. Notably, it
has been reported that Foxp3+ regulatory T cells are more
numerous in dogs with intestinal nematode infections
(Junginger et al., 2012), suggesting that mucosal tolerance
is involved in persistence of infection. Thus, interventional
strategies to neutralise Tregs could promote protective
immunity, as has been reported in some animal models
of helminth infection (Taylor et al., 2007).
Immunity to the larval stage is similarly poorly under-
stood, although important not only to the deﬁnitive canid
hosts, but also in the human setting. To date, attempts
to generate protective anti-larval immunity in laboratory
rodents have had mixed results. While an early report
noted that immunisation with somatic extracts of eggs or
adult worms resulted in approximately half the number of
surviving challenge larvae (Izzat and Olson, 1970), suscep-
tibility to larval infection was unaltered in mice immunised
with UV-irradiated eggs or larval ES antigens (Abo-Shehada
et al., 1991). Likewise, a more recent study found no evi-
dence of protection by administering a second challenge of
larvae to previously infected mice, other than they were
more likely to sequester in the brain (Kolbeková et al.,
2011). A more systematic approach, comparing immunisa-
tion and adjuvant regimes and following more closely the
resultant immune response, would help clarify this ques-
tion.
4. Toxocara spp. and allergy
Many, but not all, studies have linked human Toxo-
cara spp. infection with exacerbation of allergic disease
(reviewed by Pinelli and Aranzamendi (2012)). Children
with T. canis seroreactivity have been reported to show
more pronounced IgE and eosinophilia than seronegative
individuals as well as greater propensity for airway allergic
symptoms such as asthma (Buijs et al., 1997) and allergic
rhinitis (Yariktas et al., 2007). Mice infected with T. canis
developed compromised lung function for up to 60 days,
associated with bronchioalveolar eosinophilia and serum
IgE production (Pinelli et al., 2005). Moreover, using a pro-
tocol in mice which induces an airway allergic response
to the model antigen ovalbumin, T. canis infection prior to
ovalbumin challenge was  found to exacerbate lung pathol-
ogy (Pinelli et al., 2008).
On a broader scale, infection with T. canis might pre-
dispose human beings towards development of asthma
(Cooper, 2008). Such pro-allergic effects seemingly run
counter to a recent interpretation of the “hygiene hypoth-
esis”, which suggests that parasitic helminths dampen
allergies and other immunopathologies through their
general immune suppressive properties (Maizels, 2005).
However, it is important to recognise that T. canis is adapted
to its deﬁnitive host rather than to intermediate or acciden-
tal hosts such as the human, and in the maladapted setting,
the host may react more vigorously and pathologically.
5. Evasion of the immune response
Long-term survival of parasitic helminths in the host is
an impressive feat in the face of the well-armed immune
response, which mobilises multiple cell types and molecu-
lar mediators, including high-afﬁnity antibodies, to attack
invading organisms. T. canis larvae invade from the host
intestinal tract and disseminate throughout the tissues of
the body, remaining in an extracellular state, generating
little inﬂammatory reaction at the site of infection. There-
fore, it is implicit that T. canis is able to disable host effector
mechanisms in an extremely effective fashion.
One cell type, associated with immunity to helminths
in the tissues, is the eosinophil (Klion and Nutman, 2004;
Maizels and Balic, 2004), which is able to exgorge nox-
ious products such as major basic protein, as well as
generate superoxides (through eosinophil peroxidase) and
other damaging free radicals. Although eosinophilia is cer-
tainly a prominent feature of toxocariasis, as indeed in
many other helminth infections, it appears that T. canis is
largely resistant to attack by this cell type. In mice over-
expressing an IL-5 transgene (IL-5T) and with resultant
hypereosinophilia, T. canis larvae are unharmed, although
an unrelated helminth N. brasiliensis is eliminated (Dent
et al., 1999). Notably, when N. brasiliensis is introduced
to IL-5T mice in the presence of T. canis ES antigens
(see below), their survival is greatly enhanced (Giacomin
et al., 2008). Conversely, in IL-5-deﬁcient mice there is no
change in larval survival, although pathology in the lung
is diminished compared to wild-type (IL-5-sufﬁcient) con-
trols (Takamoto et al., 1997).
6. Shedding of the surface coat
The inability of eosinophils to kill T. canis was observed
in vitro, in experiments in which cells and larvae are co-
incubated. While in the presence of speciﬁc antibodies,
eosinophils rapidly adhered to the parasite surface, but
within 24 h the larvae had escaped from surrounding cells
(Fattah et al., 1986), leaving the eosinophils still attached
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to material which had clearly become detached from the
surface (Badley et al., 1987a).
These observations of shedding cells bound to the para-
site surface have an interesting link to electron microscopic
observations of a labile surface coat from the larval parasite,
distal to and separated from the nematode cuticle. When
larvae are treated with a lipophilic stain, a “fuzzy coat”
can be visualised, 10–20 nm thick and lying approximately
the same distance from the cuticle surface, while following
each cuticle annulation and fold (Page et al., 1992b). The
fuzzy coat can be stained with polycationic ligands such as
ferritin, indicating that it bears an overall negative charge.
Notably, the coat is lost within 2 h of co-incubating lar-
vae with antibodies reactive to the surface, elucidating the
physical basis of the original report of antibody shedding
by T. canis larvae in vitro (Smith et al., 1981).
While the ﬁrst observations of antibody shedding
employed polyclonal sera, later studies conﬁrmed this with
monoclonal antibody (MAb) reagents. In particular, two
MAbs designated Tcn-2 and Tcn-8, which bind strongly to
live larvae, and which are rapidly shed, were also demon-
strated by immuno-electron microscopy to bind the surface
coat (Page et al., 1992b). Interestingly, the same antibod-
ies were used to stain sections of larvae, and identiﬁed two
distinct secretory bodies within the larva, the oesophageal
gland opening into the buccal cavity, and the mid-body
secretory column which is a ducted secretory pore (Page
et al., 1992a).
The Tcn-2 and Tcn-8 monoclonal antibodies which bind
the surface coat, recognise related but distinct trisaccha-
ride glycan side-chains (Schabussova et al., 2007), which
are expressed on the family of mucin polypeptides, princi-
pally MUC-1, -2 and -3 collectively termed TES-120 (Loukas
et al., 2000b).  The coat and the secretory column are also
bound by the N-acetylglucosamine-speciﬁc lectin, Wheat
Germ Agglutinin (Page et al., 1992c).  While the fuzzy coat
therefore seems likely to represent a mucin- and glycan-
rich assembly, it is not yet determined if the mucins are
further covalently modiﬁed in any way, or linked to other
molecular components, in order to form a stable coat struc-
ture.
7. TES antigens and immune modulation by TES
antigens
While the ability of larvae to escape antibody and cel-
lular attack is unusual among helminth parasites, a more
general feature is modulation of the systemic immune
response to infection. In T. canis infected mice, the pro-
inﬂammatory responses of macrophages are dampened
(Kuroda et al., 2001), while susceptibility to a sub-lethal
dose of Japanese encephalitis virus is increased (Gupta and
Pavri, 1987). Recent work has reported an expansion of
the suppressive T cell subset of Foxp3+ regulatory T cells
in murine toxocariasis (Othman et al., 2011), which may
underpin some of these in vivo effects.
It is likely that both local and systemic effects of para-
site infection on host immunity are mediated by secreted
products, such as the TES antigens. As mentioned previ-
ously, TES can inhibit the protective effects of eosinophils
(Giacomin et al., 2008) and is able to induce recruitment of
both eosinophils (Sugane and Oshima, 1984) and alterna-
tively activated macrophages (Allen and MacDonald, 1998).
However, TES is a complex mixture of differing molecular
components, which require further characterisation if the
speciﬁc immunomodulatory effects of the parasite are to
be understood.
de Savigny (1975) ﬁrst reported that T. canis larvae show
remarkable longevity in vitro, allowing long-term collec-
tion of ES antigens over many months. As detailed below,
such “TES” proved to be extremely useful for diagnostic
purposes. Within TES, the molecular components were ﬁrst
described by their molecular weight on SDS-PAGE analy-
sis, with major bands evident at 26, 32, 45, 55, 70, 120 and
400 kDa (Maizels et al., 1984); even at this stage the exten-
sive overlap between surface proteins and those in TES was
clear.
Subsequent studies of TES used 1- and 2-dimensional
SDS-PAGE to more precisely classify components (Badley
et al., 1987b; Meghji and Maizels, 1986), together with
techniques such as biosynthetic labelling with radioactive
amino acids (Page and Maizels, 1992; Sugane et al., 1985).
A high degree of glycosylation was  observed, amounting to
∼40% of TES by weight (Meghji and Maizels, 1986). Histo-
logical sections of liver from infected mice also showed that
TES is released from larvae in vivo (Parsons et al., 1986).
Over subsequent years, a combination of peptide
sequencing (Loukas et al., 1999b), monoclonal antibody
binding (Bowman et al., 1993; Maizels et al., 1987) and
recombinant DNA techniques (Gems et al., 1995; Gems and
Maizels, 1996; Maizels et al., 2000) has characterised three
sets of TES proteins and glycoproteins (TES-26, -32/70 and
-120) while the other components remain to be fully char-
acterised.
7.1. TES-26: Tc-PEB-1
TES-26 is a homologue of mammalian phos-
phatidylethanolamine (PE)-binding protein and was
renamed Tc-PEB-1. It was identiﬁed initially from an
abundant mRNA bearing at its 5′ end the conserved a
nematode 22-nt spliced leader (SL1) sequence found pre-
viously in Caenorhabditis elegans (Krause and Hirsh, 1987).
While the T. canis PEB protein is similar to homologues
from other species in functionally binding PE, its structure
differs markedly in including a 72-aa N-terminal exten-
sion, containing a tandemly repeated six-cysteine motif
homologous to the potassium channel toxin of the sea
anemone, Stocihactis helianthus (Gems et al., 1995). The S.
helianthus K-toxin (ShKT) domain ﬁgures prominently in a
number of other secreted proteins not only from Toxocara
spp., but also from other nematode parasites, although as
yet has no known functional role.
7.2. TES-32 and -70: C-type lectins (CTLs)
TES-32 (Loukas et al., 1999b)  and TES-70 (Loukas
et al., 2000a)  were isolated by matching tryptic peptide
sequences from gel-puriﬁed proteins to an EST database
of larval mRNA sequences (Tetteh et al., 1999). Both are
members of the C-type lectin family; hence TES-32 was
reassigned at Tc-CTL-1. This is homologous to mammalian
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mannose-binding protein, and modelling studies which
indicated that Tc-CTL-1 does indeed bind mannose residues
were experimentally conﬁrmed (Loukas et al., 1999b).
Within the EST database were two related sequences with
minor amino acid variants which have been designated Tc-
CTL-2 and -3. A near-identical sequence was later described
by an independent group as a proteoglycan core protein
(Yamasaki et al., 1998).
Tc-CTL-1 is also one of the major larval surface proteins,
and monoclonal antibody localisation has shown that it is
expressed in the cuticle of the parasite (Page et al., 1992a).
Whether the cuticular form bears any modiﬁcation, and/or
is secreted directly from the cuticle into the larval envi-
ronment, remains to be determined. Tc-CTL-1 also appears
to be well-conserved within the Toxocara genus; the anti-
Tc-CTL-1 Mab  Tcn-3 reacts with proteins in both Toxocara
cati (Kennedy et al., 1987) and Toxocara vitulorum (Page
et al., 1991), albeit of differing molecular weights. In addi-
tion, there is signiﬁcant cross-reactivity of Tc-CTL-1 with
antibodies generated to the raccoon ascarid Baylisascaris
procyonis (Boyce et al., 1988). However, there is no cross-
reaction with ES from Toxascaris leonina (Page et al., 1991)
and mice infected with Ascaris suum do not develop serum
antibodies to Tc-CTL-1.
TES-70 is a further C-type lectin, now referred to as
Tc-CTL-4, which has been shown to bind to canine cells
in vitro. Although the mammalian ligand has yet to be iden-
tiﬁed, this is the ﬁrst instance of a TES product directly
targeting host receptors (Loukas et al., 2000a). Monoclonal
antibodies to Tc-CTL-4 also react with products in ES of
other Toxocara species, indicating that secretion of C-type
lectins might be a shared hallmark of this genus (Page et al.,
1991).
7.3. TES-120: mucins
As with TES-26, the original isolation of cDNA clones
corresponding to TES-120 antigens was facilitated by the
presence of the SL1 trans-spliced leader sequence. The con-
served sequence of the SL1 permitted full-length cloning,
without the requirement for a cDNA library or develop-
ment of speciﬁc probes (Gems and Maizels, 1996). The
most highly expressed gene encoded a mucin sequence,
designated MUC-1. Further studies established that T. canis
larvae express a set of mucin-like glycoproteins with exten-
sive Serine-Threonine rich domains which act as sites
of O-linked glycosylation, forming a surface “fuzzy coat”
described previously (Page et al., 1992b). The principal
mucins are MUC-1 (Gems and Maizels, 1996), -2 and -
3 (Loukas et al., 2000b)  with less abundant components
MUC-4 and -5 (Doedens et al., 2001), differing in struc-
ture and the relative proportions of Serine or Threonine
residues (Loukas et al., 2000b). Most strikingly, all contain
tandemly repeated ShKT domains at either or both of the
N- and C-terminal regions, ﬂanking the central mucin core.
8. Glycans of T. canis
Initial chemical analysis of TES revealed a high con-
tent of galactose and N-acetylgalactosamine, amounting to
∼40% by total weight of the secreted products (Meghji and
Maizels, 1986). However, there is only a limited degree of
N-glycoslyation, of CTL-1 and -4, as revealed by molecu-
lar weight shifts following N-glycanase digestion of total
TES products. In contrast, O-linked sugars represent the
majority of the released carbohydrates, mostly linked to
the mucin families (MUC-1 to -5).
Mass spectrometry of the O-linked sugars determined
them to be two  related trisaccharides, 2-O-Me-Fuc1-
2(4-O-Me)Gal1-3-GalNAc, and 2-O-Me-Fuc1-2Gal1-
3GalNAc, differing only in whether the central galactose
sugar bears an O-methyl side chain (Khoo et al., 1991).
Notably, the non-O-methylated form of this trisaccharide
is identical to the human blood group H antigen, providing
a structural explanation for the expression of blood group
speciﬁcities by T. canis (Smith et al., 1983). Chemical syn-
thesis of the Toxocara spp.-speciﬁc glycan structures (Amer
et al., 2001) provided material for ELISA with monoclonal
antibodies and human sera (Schabussova et al., 2007). This
conﬁrmed that the species-speciﬁc Mab, Tcn-2, recognises
the mono-methylated trisaccharide, while the shared epi-
tope present in other Toxocara species is the dimethylated
structure (Schabussova et al., 2007).
Subsequently, synthesis of the glycan Fuc1-2Gal1-
3GalNAc, omitting methylation of either the terminal
fucose or the intermediate galactose, was  used to demon-
strate loss of antibody binding, formally conﬁrming that
the Me-Gal residue is essential for this reaction (Koizumi
et al., 2012). In addition, analysis of the N-linked glycan
species in TES antigens has been undertaken, identifying
a dominant and relatively simple biantennary Man2Man-
GlcNAc-GlcNAc side chain (Khoo et al., 1993).
9. Immuno-diagnosis
The original reports from De Savigny (de Savigny and
Tizard, 1977; de Savigny et al., 1979) provided a break-
through for immuno-diagnosis of toxocariasis, as the
sensitivity and speciﬁcity of TES in assays such as ELISA
and Western Blot proved to be far superior to use of whole
worm extracts (Van Knapen et al., 1983). Indeed, the use
of TES has been successfully translated into a commer-
cial diagnostic kit (Jacquier et al., 1991). Nevertheless,
the sensitivity and speciﬁcity of TES-based immunodi-
agnostic tests vary around the 90% level, and there are
concerns that the presence of blood group-like or other
cross-reactive carbohydrates could be responsible for a
number of false-positive results (Smith et al., 1984, 2009).
The blood group-like antigens are more abundant on higher
molecular-weight TES components (TES-120 and TES-400),
and therefore a Western blotting procedure to assay human
antibodies to the lower molecular weight TES components
(TES-26 and TES-32) has also been developed (Magnaval
et al., 1991, 2002).
Recombinant proteins are now being developed for
detection of speciﬁc antibodies for toxocariasis. The TES-
32 protein (which corresponds to the C-type lectin CTL-1
(Loukas et al., 1999b)) was shown to be detected by
serum antibodies from all 9 toxocariasis patients tested.
In addition, sera from animals carrying T. cati infection
were also reactive, reﬂecting the cross-reactivity of this
protein between Toxocara species (Kennedy et al., 1987).
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In a standard ELISA assay, some 43% of sera from other
helminth infections cross-reacted with whole TES, but this
was reduced to 2% when tested against recombinant CTL-
1 adsorbed at an optimal antigen concentration (Yamasaki
et al., 2000). In a subsequent evaluation, sera from 26/215
(12%) of children from Pernambuco, Brazil, recognised Tc-
CTL-1 (TES-32) (De Andrade Lima Coêlho et al., 2005). It
should be noted that in both studies, recombinant Tc-
CTL-1 was produced as inclusion bodies in bacteria and
required 8 M urea solubilisation, indicating that a correctly
folded version of the same antigen may  show increased
immunoreactivity as this would detect conformational as
well as linear epitopes.
Most diagnostic serological tests measure total IgG anti-
bodies. In a comparative study to test an IgG4-speciﬁc
assay, it was noted that sensitivity was markedly reduced
(as many patients do not mount an IgG4 response) but
speciﬁcity was greatly enhanced compared to measuring
total IgG (Noordin et al., 2005). These authors went on
to develop an IgG4-speciﬁc diagnostic assay employing
three recombinant antigens (Tc-PEB-1 or TES-26, Tc-CTL-
1 or TES-32 also named TES-30USM, and Tc-MUC-1 or
TES120). While none of the antigens individually showed
100% speciﬁcity, a combination of the three was  able to
detect all samples serologically reactive to native TES, and
showed cross-reactivity with only 2–4% of serum samples
from other infections (Mohamad et al., 2009).
As well as recombinant proteins, the speciﬁc glycan
structures associated with T. canis also hold promise for
immuno-diagnosis. It was found that sera from human
toxocariasis patients reacted to the di-O-methylated struc-
ture 2-O-Me-Fuc1-2(4-O-Me)Gal1-3-GalNAc, although
no antibodies were detected to the species-speciﬁc
monomethylated form Schabussova et al. (2007).  As is often
the case with glycan epitopes, human antibodies were
restricted to the IgM and IgG2 isotypes.
Using polyclonal antibodies against TES in a sandwich
ELISA, circulating parasite antigens can be detected in the
serum of infected dogs, particularly pups (Matsumura et al.,
1984), and in serum of children with suspected infection
(Luo et al., 1999). Similarly, circulating antigen could be
found in both human and experimental mouse serum sam-
ples, with the monoclonal antibody Tcn-2 which recognises
a species-speciﬁc repetitive epitope that facilitates detec-
tion (Gillespie et al., 1993; Robertson et al., 1988).
10. Genomics, transcriptomics and other molecular
analyses
Despite the importance of T. canis in both veterinary
and zoonotic contexts, there is relatively little informa-
tion available at the genomic and transcriptomic levels.
Currently, the parasite genome has yet to be sequenced.
However, the 14,162-bp mitochondrial sequence has been
published (Jex et al., 2008), and the 273-Mb genome
sequence of the related parasite A. suum was recently
reported (Jex et al., 2011).
Similarly, the T. canis transcriptome is relatively under-
explored (Gasser, 2013). Over 10 years ago a small-scale
EST project on larval cDNAs was able to identify 128 distinct
genes and despite its limited scope, this study characterised
most of the major secreted antigens and a number of novel
gene families, many of which are listed in Table 1 (Tetteh
et al., 1999). A further 1975 gene clusters were assembled
from ∼5000 Sanger sequencing reads and can be searched
at http://nematode.net. More recently, a female adult cDNA
sequencing effort yielded 79 genes, including 2 C-type
lectins and an As16 homologue (Zhou et al., 2011). How-
ever, most of the identiﬁed genes have yet to be annotated
or deposited in public databases, with NCBI for example
holding only 28 distinct non-mitochondrial/ribosomal pro-
tein gene sequences at the time of writing. Much more
ambitious datasets are required to establish the protein
repertoire of T. canis and to identify patterns of stage-
speciﬁc protein expression in the parasite life cycle.
In the last few years, a new class of biological regu-
latory molecules has been deﬁned with the discovery of
small (∼22-nucleotide) RNA species which bind to and
inhibit translation of target mRNAs and mediate their
degradation within the cell. Most documented cases of
miRNA binding are to the 3′ untranslated region (3′ UTR)
downstream of the translational stop codon. Abundant
miRNAs have been described in several nematode species
(Chen et al., 2011; Poole et al., 2010; Winter et al., 2012),
most notably the free-living worm C. elegans, which pro-
vides well-characterised conserved sequences such as let-7
(Ambros et al., 2003; Hammell et al., 2009). Although no
miRNAs have yet been described in T. canis, it had been
noted that 4 abundant novel transcript (ANT) genes from
the larval stage shared highly similar 3′ UTR sequences
despite dissimilar coding sequences (Tetteh et al., 1999).
Interestingly, in the larval parasite, no evidence of proteins
corresponding to the ANT genes was found, indicating that
either gene transcription or mRNA translation was  sup-
pressed within the arrested stage. Within the 3′ UTR tracts
of each transcript were motifs similar to those targeted
in C. elegans by let-7, and when the 3′ UTR of a T. canis
ANT gene was inserted downstream of a GFP construct in
transgenic C. elegans, suppression of gene expression was
achieved (Callister et al., 2008). Thus, although the involve-
ment of canonical miRNA mechanisms in control of larval
gene expression has yet to be directly demonstrated, these
studies strongly suggest that this is the case.
11. Future prospects and priorities
Expanding our understanding of immune recognition
and evasion by T. canis is a priority if we are to appropriately
manage both human and veterinary disease. Molecular
studies to date have identiﬁed key products which are
already being used in new diagnostic assays, and doubtless
further reﬁnement will lead to the replacement of native
TES as the principal diagnostic reagent. Beyond this very
necessary innovation, two  general and interrelated areas of
research need to be addressed: by what molecular means
does T. canis suppress host immunity, and how can we
intervene to provide immunological protection in either
or both the deﬁnitive and paratenic host? These questions
should spotlight the highly evolved state of immune eva-
sion by T. canis, with every probability of deﬁning new
immunomodulatory molecules. In this way, future work
can pave the way  for rational immunological tools, most
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Table 1
Deﬁned proteins of Toxocara canis.
Abbreviation Name TES component
if applicable
Accession
number(s)
Length (incl
signal
sequence if
present)
Notes Reference
Tc-ANT-3 Abundant novel transcript-3 EU792508;
ACF19852
271 aa Callister et al.
(2008)
Tc-ANT-5 Abundant novel transcript-5 EU792509;
ACF19853
489 aa Callister et al.
(2008)
Tc-ANT-30 Abundant novel transcript-30 EU792510;
ACF19854
843 aa Callister et al.
(2008)
Tc-ANT-34 Abundant novel transcript-34 EU792511;
ACF19855
608 aa Callister et al.
(2008)
Tc-AQP-1 Aquaporin AAC32826 310 aa Loukas et al.
(1999a)
Tc-ARK-1 Arginine kinase ABK76312;
AFJ95132
Unpublished
Tc-CPL-1 Cathepsin L-like cysteine
protease
AAC48340 360 aa Loukas et al. (1998)
Tc-CPZ-1 Cathepsin Z-like cysteine
protease
AF143817 307 aa Falcone et al.
(2000)
Tc-CTL-1 C-type lectin-1 TES-32 AF041023 219 aa Binds mannose Loukas et al.
(1999b)
Proteoglycan core protein AB009305 219 aa Differs by 3 aa from
above
Yamasaki et al.
(1998)
Tc-CTL-2 C-type lectin-2 – 219 aa 17% aa divergence from
CTL-1
Tetteh et al. (1999)
Tc-CTL-3 C-type lectin-3 – 220 aa 13% aa divergence from
CTL-1
Tetteh et al. (1999)
Tc-CTL-4 C-type lectin-4 TES-70 AF126830 288 aa Binds canine cell surface Loukas et al.
(2000a)
Tc-GLB-1  Pseudocoelomic globin AAL56430;
AAL58703;
AAL58704
171 aa Minor sequence variants Unpublished
Tc-GLB-2 Intracellular globin AAL56428;
AAL56429
153 aa ∼50% identity to GLB-1 Unpublished
Tc-LDH-1 Lactate dehydrogenase AAB07368 92 aa Partial sequence Unpubished
Tc-MUC-1 Mucin-1 TES-120 AAB05820;
U39815
176 aa 15.7 kDa Serine-rich
peptide backbone with 2
ShKT domains, 39.7 kDa
total mass; 120 kDa
apparent mobility on
SDS-PAGE
Gems and Maizels
(1996)
Tc-MUC-2 Mucin-2 TES-120 AF167707 182 aa 16.2 kDa peptide with 2
ShKT domains; 47.8 kDa
total.
Loukas et al.
(2000b)
Tc-MUC-3 Mucin-3 TES-120 AF167708 269 aa 26.0 kDa threonine-rich
peptide with 4 ShKT
domains, 45.0 kDa total.
Loukas et al.
(2000b)
Tc-MUC-4 Mucin-4 TES-120 AF167709 191 aa 26.0 kDa threonine-rich
peptide with 4 ShKT
domains, 45.0 kDa total.
Tetteh et al. (1999)
Tc-MUC-5 Mucin-5 AF167710 316 aa 26.0 kDa threonine-rich
peptide with 4 ShKT
domains, 45.0 kDa total.
Doedens et al.
(2001)
Tc-MHC-1 Myosin heavy chain CAC28360 1814 aa Obwaller et al.
(2001)
Tc-MLC-1 Myosin light chain U25057 148 aa Unpublished
Tc-NPA-1 Nematode polyprotein BAA14015;
AAD01628;
AAB26196
140 aa Fragments of longer
polyprotein
Christie et al.
(1993) and
unpublished
Tc-PEB-1 Phosphatidylethanolamine-
binding
protein
TES-26 P54190,
U29761
262 aa PE-binding domain fused
with 2 ShKT domains
Gems et al. (1995)
Tc-PRO-1 Prohibitin AAB53231 274 aa Loukas and Maizels
(1998)
Tc-SLO-1 Calcium activated channel ACJ64718 1123 aa Unpublished
Tc-SOD-1 Cu–Zn superoxide dismutase AAB00227 190 aa Unpublished
Note: Gene abbreviations follow the convention of two-letter species abbreviation, a three-letter code for gene name (capitalised when referring to a protein
product) and a number to distinguish related members of the same gene family.
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importantly vaccines for use in canid species, to mimimise,
if not altogether eradicate, this important infection.
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